Vellos – a company founded by Milner Institute Director Sir Tony Kouzarides – announces partnership with Fifty Years, a renowned pre-seed and seed focused VC firm
Vellos has announced a new partnership with Fifty Years. The partnership will support and inspire the next generation of entrepreneurs across the UK’s deep tech and life sciences sectors.
Senior nurse to bring vast experience to ARU role
Ruth May, England’s former Chief Nursing Officer, joins Anglia Ruskin University.
Tozaro announces formation of Technical Advisory Board to support commercialization of Smart Polymers in cell and gene therapy bioprocessing
World-class experts from bioprocessing and cell and gene therapy (CGT) fields include Phil Vanek PhD, Carl Schoellhammer PhD, Daniel C.
Exploring treatment options for ILD
Interstitial lung disease (ILD) refers to a group of lung disorders that cause inflammation and scarring of lung tissue, leading to progressive breathing difficulties. While there is currently no cure for ILD, treatment focuses on controlling symptoms, slowing disease progression, and improving quality of life. If left untreated, ILD can lead to serious complications and early mortality…
EFEC explores UK-China Life Sciences Synergies at VBEF 2025
At Excellence First Enterprise Consultancy (EFEC), we have dedicated 19 years to forging successful UK-China partnerships, now connecting UK life sciences organisations with opportunities in China and preparing Chinese firms for success in the UK, growing together through shared innovation.
New £4.5million project to boost NHS staffing
Five-year scheme will be led in the East of England by experts from Anglia Ruskin.
Call for glaucoma classification tool to be used nationally
Glaucoma is the most frequent cause of irreversible blindness but up to 40 per cent of patients could be missing out on crucial social support, warn Cambridge experts who hope their free technology will be embraced by clinicians nationally.
ELRIG announces keynote speakers for Drug Discovery 2025
Prof Heather Pinkett and Dr Dafydd Owen to lead ELRIG’s flagship event Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate “A Festival of Life Science”Event supported by VisitBritain showcases UK life science sector and extends interna
PhoreMost makes key appointments to Board to advance development of next-generation degrader therapeutics
Barbara Duncan joins as Chair and Stephen Dilly as Non-Executive DirectorStrategic appointments support progression of PhoreMost’s next generation degrader pipeline through preclinical development and commercialisation of its GlueSEEKER® platform
Trilobio raises $8M to deliver whole lab automation for biologists
San Francisco, US, 06 May 2025: Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, announces it has raised $8 million USD Seed investment.
Why the UK life sciences sector must collaborate with China: Insights from Cedrik Neike’s perspective
Cedrik Neike, Managing Board Member of Siemens AG and CEO of Siemens Digital Industries, has provided a compelling perspective on the indispensable role China plays in maintaining the global competitiveness of German industry.
PlaqueTec announces positive early research findings from interim analysis in BIOPATTERN trial
Pre-specified interim analysis reveals differences in protein concentration between systemic blood and blood from diseased coronary arteries
Nuclera establishes distribution network across APAC and the Middle East
Operational expansion accelerates global distribution capability to increase regional access and technical supportMultiple partnerships establish direct distribution channels in China, Japan, South Korea, Singapore and IsraelCambridge, UK, and
Deloitte 2025 Technology Fast 50: The fastest growing tech companies in the UK Applications now open!
We’re delighted to announce that nominations for the 2025 UK Technology Fast 50 awards are now open! Apply today and you could join the likes of Deliveroo, Revolut and Skyscanner as a UK Technology Fast 50 winner. Application deadline: Midnight, Friday 27 June 2025
Robot-assisted double operation is an Addenbrooke’s first
A cancer patient who underwent the first robot-assisted double operation at Addenbrooke’s Hospital said on Tuesday 29th April “I was blown away by how fast it was all over.”
People, science and building biotech
Anne Horgan, Partner at Cambridge Innovation Capital, talks about what makes her tick as an investor. She will chair the discussion on Nailing the Fundraise at BioBeat25 [hyperlink]. Co-organisers, Alisa Molotova, Start-up Mentor, and Miranda Weston-Smith, BioBeat founder chat with her about her role.
Cooling for Aesthetic Laser Systems: Meeting Huge Demands with Compact Solutions
Small and compact laser systems have become a staple of the growing aesthetics market – mostly for skin treatments like hair removal. To offer a well-balanced system, manufacturers must balance several conflicting factors. This results in high demands towards the system components.
SIRS 2025: Insights on Schizophrenia Research, From Rights Based Care to Digital Biomarkers
This year’s Schizophrenia International Research Society (SIRS) 2025 Congress in Chicago brought together leading scientists and researchers, exploring the latest advancements and ongoing challenges in understanding and addressing schizophrenia. Michael Spilka, PhD. shares his key insights from SIRS 2025.
Tozaro appoints Dr. Jason Slingsby MBA as CEO to lead company strategy in cell and gene therapy sector
Established biotech leader with over 20 years’ experience including at OXB and LifeArc driving commercialization to support CGT downstream manufacturingMichele Pedrocchi PhD appointed as Non-Executive Chair of the Board of DirectorsBedfordshire
Sapio Sciences introduces Biorepository Management Solution in Sapio Release 25.4
Latest release of Sapio Platform streamlines sample workflows and delivers centralized, compliant biospecimen management
RxCelerate assembles a world-class scientific advisory board for its Biologics Discovery Unit
RxCelerate, the award-winning drug discovery and development platform, has unveiled a world-class Scientific Advisory Board (SAB) for its rapidly growing antibody discovery group, RxBiologics.
Unlocking the £100 billion opportunity: How continuous respiratory monitoring is transforming pharma economics
Co-authoured by Dr Steve Arlington, previously PWC, IBM and President of Pistoia Alliance
EFEC insight: China’s 91st CMEF and the future of global medical innovation
The 91st China International Medical Equipment Fair (CMEF), held from 8–11 April 2025 in Shanghai, underscored China’s growing prominence in medical technology and innovation. With nearly 5,000 companies from over 30 countries showcasing thousands of cutting-edge products, CMEF solidified its status as a global barometer for the medical device industry.
Astoriom appoints Ryan Smith as Global Head of Sales
Key appointment to support company in scaling biorepository and stability storage operations